MHC I on the surface of tumor cells is capable of presenting highly specific peptides called neoantigens. Since they are not expressed in normal cells, these peptides are ideal targets for tumor immunotherapy and tumor vaccines. In recent years, immunotherapy based on tumor neoantigens has received significant attention, but the accurate identification of tumor-specific neoantigens from the...